Previous 10 | Next 10 |
Zynex, Inc Announces New Therapy Products PR Newswire ENGLEWOOD, Colo. , Aug. 9, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management...
Zynex, Inc Founder and CEO Thomas Sandgaard to participate in Benzinga's Pharma Companies vs. A Tough Macro Backdrop Free Webinar on August 3rd at 12:15 PM ET PR Newswire ENGLEWOOD, Colo. , Aug. 3, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medica...
2023-07-27 20:14:20 ET Zynex, Inc. (ZYXI) Q2 2023 Earnings Conference Call July 27, 2023, 04:15 PM ET Company Participants Quinn Callanan - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive Officer Anna Lucsok - Chief Operating Off...
2023-07-27 17:05:40 ET Zynex press release ( NASDAQ: ZYXI ): Q2 GAAP EPS of $0.09 beats by $0.05 . Revenue of $44.95M (+22.3% Y/Y) beats by $0.29M . The growth in net revenue is primarily related to a 51% growth in device orders, which resulted from an increase...
Zynex Reports Second Quarter 2023 Financial Results PR Newswire Q2 2023 Revenue increased 22% to $45.0 Million ; EPS $0.09 ENGLEWOOD, Colo. , July 27, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specia...
Zynex, Inc. Sets Second Quarter 2023 Earnings Call PR Newswire ENGLEWOOD, Colo. , July 20, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain ...
Zynex, Inc. (NASD: ZYXI) Wins 2023 National Top Workplaces Award in the Manufacturing Industry Category PR Newswire ENGLEWOOD, Colo. , July 17, 2023 /PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative medical technology company specializing in the manufactu...
2023-07-16 03:33:02 ET Summary Zynex, a medical device manufacturer, has reported a 36% year-over-year increase in revenue in Q1 2023, reaching $42.2 million, with a 14% increase in net income. Despite short-term underperformance, the company shows strong profitability and growth ...
2023-07-12 10:24:31 ET Zynex ( NASDAQ: ZYXI ) reiterates its full year 2023 guidance of revenue between $180 - $200M vs. consensus of $192.68M and EPS between $0.40 - $0.50 vs. consensus of $0.45. The Co. continues to see strong growth in its pain management division a...
Zynex Reports Preliminary Second Quarter 2023 Results PR Newswire ENGLEWOOD, Colo. , July 12, 2023 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices f...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orde...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...